Procedural success, safety and patients satisfaction after second ablation of atrial fibrillation in the elderly: results from the German Ablation Registry.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 01 12 2018
accepted: 25 03 2019
pubmed: 7 4 2019
medline: 15 4 2020
entrez: 7 4 2019
Statut: ppublish

Résumé

Aged patients are underrepresented in clinical trials on catheter ablation of atrial fibrillation (AF). In addition, results of outcomes after repeat ablation in the elderly are lacking. We report the results of first repeat AF ablation procedures of aged patients from a real-world multicenter prospective registry. Patients undergoing second AF ablation included in the prospective, multicenter German Ablation Registry were divided in two groups (age > 70 years (group 1) and age ≤ 70 years (group 2)) and analyzed for procedural characteristics and clinical follow-up. 738 patients were analyzed (108 patients in group 1, 630 patients in group 2). Significantly more aged patients had structural heart disease (56 patients (51.9%) vs. 203 patients (32.2%), p < 0.001). The majority of the patients underwent repeat pulmonary vein isolation (101 patients (93.5%) vs. 593 patients (94.1%), p = 0.98). More aged patients underwent ablation of left atrial linear lesions (78.1% vs. 57.3% of all linear lesions, p = 0.027). There was no difference in the occurrence of peri-procedural complications (7 patients (6.5%) vs. 24 patients (3.8%), p = 0.30). Recurrence of atrial arrhythmias was documented in 45/105 (42.9%) and 252/603 (41.8%) patients with available follow-up in groups 1 and 2 after a median of 447 (400; 532) and 473 (411; 544) days (p = 0.84). A comparable amount of patients were asymptomatic or reported symptom improvement after repeat ablation in both groups (80% (80/100) in group 1 and 77% (446/576) in group 2; p = 0.57). Repeat ablation for AF in elderly patients can be performed with safety and efficacy comparable to younger patients.

Sections du résumé

BACKGROUND BACKGROUND
Aged patients are underrepresented in clinical trials on catheter ablation of atrial fibrillation (AF). In addition, results of outcomes after repeat ablation in the elderly are lacking. We report the results of first repeat AF ablation procedures of aged patients from a real-world multicenter prospective registry.
METHODS METHODS
Patients undergoing second AF ablation included in the prospective, multicenter German Ablation Registry were divided in two groups (age > 70 years (group 1) and age ≤ 70 years (group 2)) and analyzed for procedural characteristics and clinical follow-up.
RESULTS RESULTS
738 patients were analyzed (108 patients in group 1, 630 patients in group 2). Significantly more aged patients had structural heart disease (56 patients (51.9%) vs. 203 patients (32.2%), p < 0.001). The majority of the patients underwent repeat pulmonary vein isolation (101 patients (93.5%) vs. 593 patients (94.1%), p = 0.98). More aged patients underwent ablation of left atrial linear lesions (78.1% vs. 57.3% of all linear lesions, p = 0.027). There was no difference in the occurrence of peri-procedural complications (7 patients (6.5%) vs. 24 patients (3.8%), p = 0.30). Recurrence of atrial arrhythmias was documented in 45/105 (42.9%) and 252/603 (41.8%) patients with available follow-up in groups 1 and 2 after a median of 447 (400; 532) and 473 (411; 544) days (p = 0.84). A comparable amount of patients were asymptomatic or reported symptom improvement after repeat ablation in both groups (80% (80/100) in group 1 and 77% (446/576) in group 2; p = 0.57).
CONCLUSION CONCLUSIONS
Repeat ablation for AF in elderly patients can be performed with safety and efficacy comparable to younger patients.

Identifiants

pubmed: 30953179
doi: 10.1007/s00392-019-01471-5
pii: 10.1007/s00392-019-01471-5
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1354-1363

Références

Clin Res Cardiol. 2018 Nov;107(11):1021-1032
pubmed: 29744616
Europace. 2017 Nov 1;19(11):1798-1803
pubmed: 28402529
J Cardiovasc Electrophysiol. 2008 Jun;19(6):621-6
pubmed: 18462325
Clin Res Cardiol. 2018 May;107(5):405-412
pubmed: 29285621
J Cardiovasc Electrophysiol. 2013 Jul;24(7):731-8
pubmed: 23551460
J Geriatr Cardiol. 2017 Sep;14(9):563-568
pubmed: 29144514
J Cardiovasc Electrophysiol. 2017 Mar;28(3):258-265
pubmed: 27925337
Europace. 2016 Apr;18(4):543-9
pubmed: 26826139
JACC Clin Electrophysiol. 2017 Feb;3(2):154-161
pubmed: 29759388
J Am Coll Cardiol. 2012 Nov 6;60(19):1921-9
pubmed: 23062545
Circ Arrhythm Electrophysiol. 2010 Oct;3(5):452-7
pubmed: 20858861
Circ Arrhythm Electrophysiol. 2010 Feb;3(1):32-8
pubmed: 19995881
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
Europace. 2018 Jul 1;20(7):1086-1092
pubmed: 29016990
J Cardiovasc Electrophysiol. 2008 Aug;19(8):807-11
pubmed: 18363688
J Cardiovasc Electrophysiol. 2016 Feb;27(2):141-6
pubmed: 26443666
Circulation. 2013 Nov 5;128(19):2104-12
pubmed: 24061087
Circulation. 2010 Dec 7;122(23):2368-77
pubmed: 21098450
Clin Res Cardiol. 2019 Jul;108(7):815-823
pubmed: 30788620
Clin Res Cardiol. 2018 Nov;107(11):1003-1012
pubmed: 29740700
Europace. 2018 May 1;20(5):772-777
pubmed: 29741689
Heart Rhythm. 2015 Jan;12(1):44-51
pubmed: 25257091
JACC Clin Electrophysiol. 2017 Aug;3(8):875-883
pubmed: 29759785
Int J Cardiol. 2019 Mar 1;278:108-113
pubmed: 30287056
J Cardiovasc Electrophysiol. 2012 Jul;23(7):687-93
pubmed: 22494628

Auteurs

Thomas Fink (T)

Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Germany. thomas_fink47@gmx.de.
Department of Cardiology, Angiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. thomas_fink47@gmx.de.

Andreas Metzner (A)

Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Germany.

Stephan Willems (S)

Universitätsklinik Hamburg-Eppendorf, Hamburg, Germany.

Lars Eckardt (L)

Klinik für Kardiologie II: Rhythmologie, Universitätsklinikum Münster, Münster, Germany.

Hüseyin Ince (H)

Klinik für Kardiologie und Internistische Intensivmedizin, Vivantes Klinikum Am Urban und im Friedrichshain, Berlin, Germany.
Abteilung für Kardiologie, Universitätsmedizin Rostock, Rostock, Germany.

Johannes Brachmann (J)

Klinik für Kardiologie, Angiologie und Pneumologie, Coburg, Germany.

Stefan G Spitzer (SG)

Praxisklinik Herz und Gefäße Dresden, Akademische Lehrpraxisklinik der TU Dresden and Institute of Medical Technology, Brandenburg University of Technology Cottbus, Senftenberg, Germany.

Thomas Deneke (T)

Herz- und Gefäßklinik Bad Neustadt, Bad Neustadt, Germany.

Claus Schmitt (C)

Städtisches Klinikum Karlsruhe, Medizinische Klinik IV, Karlsruhe, Germany.

Matthias Hochadel (M)

Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany.

Jochen Senges (J)

Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen am Rhein, Germany.

Andreas Rillig (A)

Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Germany.
Charité Herzmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH